Jointown Pharmaceutical Group Overview
- Year Founded
-
1999
- Status
-
Public
- Employees
-
29,862
- Stock Symbol
-
600998
- Investments
-
24
- Share Price
-
$0.76
- (As of Friday Closing)
Jointown Pharmaceutical Group General Information
Description
Jointown Pharmaceutical Group Co Ltd is engaged in the business of wholesaling drugs and medical devices. The company offers logistics and other value-added services and mainly serves medical institutions, wholesale enterprises, and retail pharmacies.
Contact Information
Website
www.jointown.comCorporate Office
- Number 5, Longxing West Street
- Hanyang District
- Wuhan, Hubei 430051
- China
Corporate Office
- Number 5, Longxing West Street
- Hanyang District
- Wuhan, Hubei 430051
- China
Jointown Pharmaceutical Group Stock Performance
As of 13-Nov-2026, Jointown Pharmaceutical Group’s stock price is $0.76. Its current market cap is $3.85B with 5.04B shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.76 | $0.77 | $0.66 - $0.84 | $3.85B | 5.04B | 37.4M | $0.06 |
Jointown Pharmaceutical Group Financials Summary
As of 30-Sep-2026, Jointown Pharmaceutical Group has a trailing 12-month revenue of $24.9B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 4,807,803 | 4,607,355 | 4,398,369 | 4,805,714 |
| Revenue | 24,882,722 | 22,442,332 | 21,156,804 | 21,221,540 |
| EBITDA | 557,662 | 695,151 | 781,564 | 687,034 |
| Net Income | 284,590 | 313,554 | 349,440 | 307,290 |
| Total Assets | 18,568,462 | 16,637,477 | 14,026,639 | 13,089,905 |
| Total Debt | 2,604,122 | 2,156,902 | 1,812,144 | 2,080,596 |
Jointown Pharmaceutical Group Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Jointown Pharmaceutical Group Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Jointown Pharmaceutical Group Investments & Acquisitions (24)
Jointown Pharmaceutical Group’s most recent deal was a Later Stage VC with Thyssen Pharmaceuticals. The deal was made on 23-Dec-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Thyssen Pharmaceuticals | 23-Dec-2024 | Later Stage VC | Pharmaceuticals | ||
| WEMT Medical | 25-Sep-2024 | Early Stage VC | Surgical Devices | ||
| Yuntai Network | 07-Nov-2023 | Later Stage VC | Enterprise Systems (Healthcare) | ||
| Jiu Zhou Yi Yao Gong Ying Lian | 23-Oct-2023 | Joint Venture | Information Services (B2C) | ||
| Hubei Xinzongke | 23-Sep-2022 | Later Stage VC | Diagnostic Equipment |
Jointown Pharmaceutical Group ESG
Risk Overview
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Distribution
Subindustry
Rank
Percentile
Jointown Pharmaceutical Group Exits (5)
Jointown Pharmaceutical Group’s most recent exit was on 07-Nov-2023 from Yuntai Network. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Yuntai Network | 07-Nov-2023 | Completed |
|
||
| Zhongke Tongda | 10-Jul-2019 | Completed |
|
||
| Hongyuan Pharmaceutical Technology | 16-Feb-2016 | Completed |
|
||
| Kaxingtianxia | 07-Sep-2015 | Completed |
|
||
| Kaxingtianxia | 06-May-2014 | Early Stage VC | Completed |
|
Jointown Pharmaceutical Group Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Liyang Supply Chain | Wuhan, China | 2019 | |
| Jk.com | Industry, CA | 2016 | |
| Starside Drugs | New York, NY | 1981 |
Jointown Pharmaceutical Group FAQs
-
When was Jointown Pharmaceutical Group founded?
Jointown Pharmaceutical Group was founded in 1999.
-
Where is Jointown Pharmaceutical Group headquartered?
Jointown Pharmaceutical Group is headquartered in Wuhan, China.
-
What is the size of Jointown Pharmaceutical Group?
Jointown Pharmaceutical Group has 29,862 total employees.
-
What industry is Jointown Pharmaceutical Group in?
Jointown Pharmaceutical Group’s primary industry is Distributors (Healthcare).
-
Is Jointown Pharmaceutical Group a private or public company?
Jointown Pharmaceutical Group is a Public company.
-
What is Jointown Pharmaceutical Group’s stock symbol?
The ticker symbol for Jointown Pharmaceutical Group is 600998.
-
What is the current stock price of Jointown Pharmaceutical Group?
As of 13-Nov-2026 the stock price of Jointown Pharmaceutical Group is $0.76.
-
What is the current market cap of Jointown Pharmaceutical Group?
The current market capitalization of Jointown Pharmaceutical Group is $3.85B.
-
What is Jointown Pharmaceutical Group’s current revenue?
The trailing twelve month revenue for Jointown Pharmaceutical Group is $24.9B.
-
What is Jointown Pharmaceutical Group’s annual earnings per share (EPS)?
Jointown Pharmaceutical Group’s EPS for 12 months was $0.06.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
